| CTLT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CTLT shares outstanding history going back to 9/1/2014:
Also see: CTLT Market Cap History CTLT YTD Return |
CTLT Shares Outstanding History — Catalent Share Count Over Time
As of 10/23/2024 Catalent has 181.51 million CTLT shares outstanding. Investors often track the CTLT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CTLT share count trends over time, with 41 historical shares outstanding datapoints presented, dating back to 9/1/2014.
| CTLT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CTLT Historical Shares Outstanding: +4.39% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CTLT Stock Price Chart |
| About Catalent Inc |
| Catalent, Inc. is engaged in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. Co.'s Biologics segment provides formulation, development, and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells (iPSCs); oncolytic viruses, and vaccines. It also provides formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges, and analytical development and testing services for large molecules. We show 41 historical shares outstanding datapoints in our coverage of CTLT's shares outstanding history. Understanding the changing numbers of CTLT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CTLT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CTLT by allowing them to research CTLT shares outstanding history as well as any other stock in our coverage universe. |
| CTLT Current Stock Quote |
Quotes delayed 20 minutes  Free CTLT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CTLT Share Performance |
| Shares Outstanding Peers |
| Catalent (CTLT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CTMX Shares Outstanding History CTNM Shares Outstanding History CTRV Shares Outstanding History CTSO Shares Outstanding History CTXR Shares Outstanding History CUE Shares Outstanding History CUR Shares Outstanding History CUTR Shares Outstanding History CVKD Shares Outstanding History CVRX Shares Outstanding History More Healthcare companies » |
CTLT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
